Your browser doesn't support javascript.
loading
Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022.
Ladhani, Shamez N; Aiano, Felicity; Edwards, David S; Perkins, Samantha; Khan, Wazirzada M; Iyanger, Nalini; Whittaker, Elizabeth; Cohen, Jonathan M; Ho, David; Hopkins, Susan; Ramsay, Mary E; Chow, J Yimmy.
Afiliación
  • Ladhani SN; Immunisation Division, UK Health Security Agency, London, United Kingdom.
  • Aiano F; Paediatric Infectious Diseases Research Group, St. George's University of London, London, United Kingdom.
  • Edwards DS; Immunisation Division, UK Health Security Agency, London, United Kingdom.
  • Perkins S; UK Health Security Agency East of England Health Protection Team, Mildenhall, United Kingdom.
  • Khan WM; UK Health Security Agency, South London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.
  • Iyanger N; UK Health Security Agency, South London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.
  • Whittaker E; UK Health Security Agency Northwest London Health Protection Team and the London Coordination and Response Cell, London, United Kingdom.
  • Cohen JM; Paediatric Infectious Diseases Department, Imperial College London, London, United Kingdom.
  • Ho D; Paediatric Immunology and Infectious Diseases, Evelina London Children's Hospital, London, United Kingdom.
  • Hopkins S; Paediatric Immunology and Infectious Diseases, Evelina London Children's Hospital, London, United Kingdom.
  • Ramsay ME; Clinical and Public Health Group, UK Health Security Agency, London, United Kingdom.
  • Chow JY; Immunisation Division, UK Health Security Agency, London, United Kingdom.
Euro Surveill ; 27(40)2022 10.
Article en En | MEDLINE | ID: mdl-36205169
ABSTRACT
We investigated a secondary school (11-16 year-olds), a primary school (5-11 year-olds), reception year (4-5 year-olds) and a nursery (2-5 year-olds) following confirmed monkeypox in an adult in each educational setting during June and July 2022. MVA-BN vaccine was offered up to 14 days post exposure to 186 children < 12 years and 21 were vaccinated. No secondary cases occurred among at least 340 exposed students and more than 100 exposed staff during the 28-day follow-up period.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mpox Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Adult / Child / Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mpox Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Adult / Child / Humans País/Región como asunto: Europa Idioma: En Revista: Euro Surveill Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido